Dr. Morris contacted Claire directly at 7:14 that evening.
The call came from an unknown number.
Claire almost ignored it.
Then the woman said, “If you want Sophie alive next year, don’t let them give her the second cycle.”
Claire stood so quickly her chair struck the wall.
Daniel looked up.
Bell, sitting near the doorway, immediately understood something was wrong.
Claire switched the phone to speaker.
“Dr. Morris?”
A pause.
“So they identified me.”
Bell silently signaled another agent to begin tracing the call.
Claire forced herself to stay calm.
“Where are you?”
“That doesn’t matter.”
“You changed my daughter’s medication order.”
“I corrected what they were about to do.”
“You entered a dose that could have killed her.”
“No.”
Dr. Morris sounded genuinely offended.
“The system converted the unit incorrectly after I accessed it.”
Bell mouthed, Keep her talking.
Claire ignored whether the explanation was true.
“You stole Sophie’s tumor.”
“I borrowed it.”
“You replaced it.”
“Because I needed time to analyze it before Shah’s team destroyed evidence.”
Dr. Shah had entered the room during the call.
She heard her name.
“You could have requested access.”
Morris laughed bitterly.
“You would have denied it.”
“Yes,” Dr. Shah said. “Because you attempted to interfere with a patient’s treatment.”
“You don’t understand what you’re treating.”
“I understand malignant germ-cell disease.”
“You understand the phenotype. Not the mechanism.”
Sophie was awake now.
Claire wished she weren’t listening.
“What mechanism?” she asked.
Morris hesitated.
Then Sophie spoke.
“You can tell me. It’s my body.”
Silence followed.
When Morris answered, her voice changed.
Less combative.
More careful.
She explained that Samuel’s original vector had not simply tried to repair the inherited mutation.
It had inserted a regulatory switch designed to activate only when abnormal cells appeared.
A kind of biological alarm.
For years, Sophie’s modified cells may have recognized early cancer changes and destroyed them.
Claire looked at Dr. Shah.
“Is that possible?”
“In theory.”
Morris continued.
The problem was that the regulatory switch had become unstable.
Instead of activating only when dangerous cells appeared, parts of it had begun switching on in healthy tissue.
The resulting cellular signaling could encourage uncontrolled growth.
Kevin.
Gertrude.
Possibly both.
Daniel looked furious.
“So Samuel created a cancer-prevention system that can cause cancer.”
“Yes.”
Sophie frowned.
“That’s stupid.”
Morris gave a short, exhausted laugh.
“It was ambitious.”
“It was stupid.”
Nobody corrected her.
Claire returned to the real question.
“Why are you saying chemotherapy is dangerous?”
“Because Samuel designed the vector to respond to certain types of cell damage.”
Dr. Shah’s expression tightened.
“What kind?”
“DNA damage.”
Chemotherapy worked partly by damaging the DNA of rapidly dividing cancer cells.
Morris believed the treatment might activate the unstable vector across healthy tissues.
Dr. Shah shook her head.
“You don’t know that.”
“I've seen it happen.”
Everyone went silent.
“With whom?” Claire asked.
Morris did not answer.
Bell stepped closer.
“Dr. Morris, children were injured in this research. If you have clinical data, you need to surrender it.”
“I tried.”
“To whom?”
“NorthStar.”
“That’s not surrendering data.”
“I was inside the project. I thought I could correct it.”
Claire closed her eyes.
Another person who believed being inside the danger gave them the right to manage it secretly.
“How long have you known Sophie was sick?”
Morris hesitated.
“Three months.”
Daniel stood.
“You knew a ten-year-old child had brain cancer for three months?”
“We didn’t know it was malignant then.”
“You knew there was a mass.”
“Yes.”
“And you watched it.”
“We needed serial imaging.”
Daniel’s voice dropped.
“You needed data.”
Morris did not answer.
Sophie stared at the phone.
“Why didn’t you tell my mom?”
Morris finally sounded ashamed.
“Because Samuel believed we could treat you without conventional oncology.”
“But you didn’t.”
“No.”
“Why?”
“Because our rescue vector wasn't ready.”
Sophie looked at Claire.
“Then they were waiting for medicine they hadn’t made yet.”
Claire nodded.
Her anger had become almost clean now.
Samuel and Morris had gambled with Sophie’s life because they trusted their future solution more than existing medicine.
Dr. Shah took over.
“What evidence supports your claim about chemotherapy activating the vector?”
Morris said she had laboratory data from another child.
“Name.”
“No.”
“If you want us to alter Sophie’s treatment, I need the data.”
“I'll send it.”
“To the hospital?”
“To Claire.”
Bell shook his head.
Claire ignored him.
“Send everything.”
Morris did.
Minutes later a secure file link arrived.
Bell’s cyber team isolated the documents before Dr. Shah reviewed them.
The records concerned another child treated with Samuel’s vector.
Subject 04.
A girl named Maya Cole.
At age eight she developed lymphoma.
She received standard chemotherapy.
Within weeks, multiple new lesions appeared in organs previously unaffected.
Morris claimed the pattern resulted from vector activation.
Dr. Shah read every page.
Claire watched her face.
Finally she said, “This is concerning.”
Daniel leaned forward.
“Concerning how?”
“It’s not proof. The disease itself could explain some of this progression.”
“But not all?”
“I don't know yet.”
Claire hated those words.
Morris remained on the line.
“Samuel built the rescue vector for Sophie because her modified cells still carry the original switch. The new vector is designed to deactivate it.”
“The vials in the silver case?” Claire asked.
“Yes.”
“Are they safe?”
“No.”
The immediate answer surprised everyone.
Morris continued.
“We have animal data. Limited cellular testing. No human safety trial.”
Daniel stared at the phone.
“And you want us to inject it into her?”
“I want you to stop damaging her cells until we know whether you can safely disable the switch.”
Dr. Shah responded.
“If we pause treatment and the brain tumor progresses, Sophie could deteriorate quickly.”
Claire looked at Sophie.
There it was.
The choice nobody should have been forced to make.
Continue a treatment with decades of evidence behind it but a newly discovered theoretical risk.
Or delay that treatment because an illegal experiment might have changed the rules of Sophie’s biology.
Sophie looked at the adults.
“What would you do if I wasn’t Grandpa’s experiment?”
Dr. Shah answered.
“Treat the cancer.”
“Then treat it.”
Morris interrupted.
“Sophie—”
“No.”
Her voice was stronger now.
“You knew for three months.”
Morris went quiet.
“You watched Kevin grow because you wanted to test your medicine.”
“We were trying to save you.”
“No, you were trying to be right.”
Claire felt tears rise unexpectedly.
Sophie continued.
“If your new medicine works someday, good. But I'm not waiting for you to finish your homework.”
Daniel lowered his head.
Dr. Shah looked at Claire.
The decision legally belonged to the adults, but everyone understood Sophie had just made herself part of it.
Claire asked the oncologist one question.
“If this were your daughter?”
Dr. Shah hesitated.
Then she answered without hiding behind professional language.
“I would continue standard treatment while urgently investigating the vector risk.”
Claire nodded.
“That's what we do.”
Morris exhaled.
“You may regret this.”
Claire stared at the phone.
“I already regret trusting people who decided Sophie was research before she was a child.”
Bell asked Morris to surrender.
She refused.
“Not yet.”
“Why?”
“Because Samuel wasn't running the project anymore.”
Eric, who had been silent near the window, looked up.
“What?”
Morris said Samuel had been pushed out nearly two years earlier.
“By whom?”
“The people funding it.”
NorthStar had changed leadership.
The experiment had become too valuable.
The gene-editing platform Samuel developed could be worth billions if its cancer-prevention mechanism could be stabilized.
Children like Sophie were no longer simply research subjects.
They were proprietary evidence.
Claire stared at the phone.
“Who owns it?”
“Legally? Several shell companies.”
“Who controls them?”
Morris hesitated.
Bell leaned toward the phone.
“Name.”
Morris whispered it.
“Victor Lang.”
Eric stood.
Claire recognized his reaction.
“You know him.”
Eric nodded.
“NorthStar’s former CEO.”
Morris continued.
Lang had authorized the hidden clinics.
The erased hospital records.
The sample collection.
The surveillance.
Samuel had objected only after Sophie’s tumors appeared.
Until then he'd tolerated it.
Then he tried to remove her from the study and use his rescue vector.
Lang refused.
The instruction DO NOT ALLOW TREATMENT had not meant standard oncology.
It meant Samuel’s treatment.
Claire understood.
Two groups had been fighting over Sophie.
Samuel wanted to use an unfinished genetic rescue.
Lang wanted the experiment preserved long enough to understand its failure.
Neither had told Sophie she was sick.
Neither had asked what she wanted.
Bell ordered Morris to give them Lang’s location.
“I don't know.”
“Then tell us where you are.”
Morris hesitated.
A noise sounded through the phone.
A door.
Then footsteps.
Morris inhaled sharply.
“Someone’s here.”
Bell stood.
“Where are you?”
She whispered an address.
Bell repeated it to the agents.
The phone shifted.
A man’s voice sounded faintly in the background.
Morris said, “You shouldn't be here.”
Then the call ended.
Federal agents reached the address twelve minutes later.
It was a small private laboratory registered to a NorthStar subsidiary.
The door was open.
Nobody was inside.
Dr. Morris was gone.
On a stainless-steel table sat a laptop.
Beside it lay three empty sample tubes.
One contained blood matching Sophie.
Another belonged to Samuel.
The third had no label.
On the computer screen was a live video feed.
Sophie’s hospital room.
Claire looked toward the ceiling.
Someone had been watching them the entire time.
